ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,426, issued on Jan. 13.
"Methods and compositions for inhibiting glyoxalase 1 (GLO1)" was invented by Abraham Palmer (La Jolla, Calif.), Margaret Distler (Los Angeles) and Katherine M. J. McMurray (Oxford, Ohio).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions are provided for treating or preventing a neurological disease or disorder using an inhibitor of Glyoxalase 1 (GLO1). In some embodiments, the inhibitor is a small molecule. In certain embodiments, the disease or disorder is a sleep disorder, a mood disorder such as depression, epilepsy, an anxiety disorder, substance abuse, substance dependence or substance such as an al...